HR 2565 United States House · 117th Congress

FDA Modernization Act of 2021

Summary

FDA Modernization Act of 2021 This bill allows an applicant for market approval for a new drug to use methods other than animal testing to establish the drug's safety and effectiveness. Under this bill, these alternative methods may include cell-based assays, organ chips and microphysiological systems, sophisticated computer modeling, and other human biology-based test methods.

Bill status in committee 1 of 4 stages cleared

Introduction

Apr 2021

Committee Review

Floor Vote

President

Introduced Apr 15, 2021 Last action Apr 16, 2021

Floor votes

How they voted

No floor votes recorded yet.

Full legislative history

Actions timeline

Total actions

3

Key actions

0

Committee

2

Apr 16, 2021

Committee

Referred to the Subcommittee on Health.

lower

Apr 15, 2021

Committee

Referred to the House Committee on Energy and Commerce.

lower

Apr 15, 2021

Introduced

Introduced in House

lower

1 primary · 114 co-sponsors

Sponsors

Role

Legislator

Party

State

District

A. Donald McEachin

Abigail Davis Spanberger

Andrew R. Garbarino